Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dittadi

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Oncology Reports|May 21, 2011
Epidermal growth-factor receptors and erbb2 protein expression in esophageal cancer and normal mucosaR Dittadi, A Ruol, M Gion, et al.
The International Journal of Biological Markers|June 6, 2007
Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen: two not always related itemsR Dittadi, R Franceschini, A Fortunato, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancerM Gion, R Mione, R Dittadi, et al.
Angiogenesis|January 1, 1997
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implicationsM Toi, M Gion, E Biganzoli, et al.
Anticancer Research|March 12, 1998
Quantitative chemiluminescent immunoassay of p53: prognostic significance in 220 node-negative breast cancer tissueR Dittadi, A Brazzale, R Mione, et al.
Pathologica|August 1, 1997
[Expression of estrogen receptors in breast cancer detected by various methods: lack of correlation]M Barbareschi, L Losi, G Capitanio, et al.
Tumori|October 31, 1985
Estrogen and progesterone receptors in breast carcinoma and in nonmalignant breast tissueM Gion, R Mione, R Dittadi, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinomaM Gion, R Mione, C Tremolada, et al.
Breast Cancer Research and Treatment|June 1, 2000
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosisM Gion, P Boracchi, R Dittadi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neckE Ferruzzi, R Franceschini, G Cazzolato, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oncology Reports|May 21, 2011
Epidermal growth-factor receptors and erbb2 protein expression in esophageal cancer and normal mucosaR Dittadi, A Ruol, M Gion, et al.
The International Journal of Biological Markers|June 6, 2007
Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen: two not always related itemsR Dittadi, R Franceschini, A Fortunato, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancerM Gion, R Mione, R Dittadi, et al.
Angiogenesis|January 1, 1997
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implicationsM Toi, M Gion, E Biganzoli, et al.
Anticancer Research|March 12, 1998
Quantitative chemiluminescent immunoassay of p53: prognostic significance in 220 node-negative breast cancer tissueR Dittadi, A Brazzale, R Mione, et al.
Pathologica|August 1, 1997
[Expression of estrogen receptors in breast cancer detected by various methods: lack of correlation]M Barbareschi, L Losi, G Capitanio, et al.
Tumori|October 31, 1985
Estrogen and progesterone receptors in breast carcinoma and in nonmalignant breast tissueM Gion, R Mione, R Dittadi, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1991
Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinomaM Gion, R Mione, C Tremolada, et al.
Breast Cancer Research and Treatment|June 1, 2000
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosisM Gion, P Boracchi, R Dittadi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neckE Ferruzzi, R Franceschini, G Cazzolato, et al.
Pageof 5